Literature DB >> 12687660

Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma.

Paola Origone1, Raffaella Defferrari, Katia Mazzocco, Crocifissa Lo Cunsolo, Bruno De Bernardi, Gian Paolo Tonini.   

Abstract

Neurofibromatosis type 1 (NF1) patients are susceptible to tumor development. In the present study we describe a child with NF1 and disseminated neuroblastoma whose death resulted from disease progression. The mother had café-au-lait spots suggesting a familial NF1. Neuroblastoma cells showed MYCN amplification and chromosome 1p36 deletion, common features associated with tumor progression in this malignancy. The NF1 gene displayed a germline T --> C transition of intron 14 in both the proband and mother DNA. This mutation, not yet previously described, occurs in a splicing donor site and produces a new mRNA variant observed together with normal NF1 mRNA. Furthermore, the SSCP analysis of the NF1 gene in tumor cells showed a somatic deletion encompassing the intron 26 and 27b of the paternal NF1 allele. Hence, neuroblastoma cells displayed both somatic and germline mutation of the NF1 gene. Our data suggest that, although rare, neuroblastoma in patients with NF1 may display homozygous gene inactivation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12687660     DOI: 10.1002/ajmg.a.10167

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

Review 2.  Ganglioneuroma of the pancreas in a 4-year-old girl.

Authors:  Naruhiko Ikoma; Juan A Santamaria-Barria; Curtis Wray; KuoJen Tsao
Journal:  BMJ Case Rep       Date:  2016-11-14

3.  NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

Authors:  Michael Hölzel; Sidong Huang; Jan Koster; Ingrid Ora; Arjan Lakeman; Huib Caron; Wouter Nijkamp; Jing Xie; Tom Callens; Shahab Asgharzadeh; Robert C Seeger; Ludwine Messiaen; Rogier Versteeg; René Bernards
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

4.  Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.

Authors:  Helena Carén; Anna Djos; Maria Nethander; Rose-Marie Sjöberg; Per Kogner; Camilla Enström; Staffan Nilsson; Tommy Martinsson
Journal:  BMC Cancer       Date:  2011-02-11       Impact factor: 4.430

Review 5.  Genetic susceptibility to neuroblastoma: current knowledge and future directions.

Authors:  Laura E Ritenour; Michael P Randall; Kristopher R Bosse; Sharon J Diskin
Journal:  Cell Tissue Res       Date:  2018-03-27       Impact factor: 5.249

Review 6.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Authors:  Junne Kamihara; Franck Bourdeaut; William D Foulkes; Jan J Molenaar; Yaël P Mossé; Akira Nakagawara; Andreu Parareda; Sarah R Scollon; Kami Wolfe Schneider; Alison H Skalet; Lisa J States; Michael F Walsh; Lisa R Diller; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

Review 7.  Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Authors:  Kristopher R Bosse; John M Maris
Journal:  Cancer       Date:  2015-11-05       Impact factor: 6.860

Review 8.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

9.  Adrenal Ganglioneuroblastoma in Adults: A Case Report and Review of the Literature.

Authors:  Stefano Benedini; Giorgia Grassi; Carmen Aresta; Antonietta Tufano; Luca Fabio Carmignani; Barbara Rubino; Livio Luzi; Sabrina Corbetta
Journal:  Case Rep Endocrinol       Date:  2017-06-21

10.  High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Authors:  Helena Carén; Jennie Erichsen; Linda Olsson; Charlotta Enerbäck; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  BMC Genomics       Date:  2008-07-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.